Related Experiment Videos
Temporal trends in U.S. mortality from liver cirrhosis and sepsis: A 25-year retrospective analysis (1999-2023)
Muhammad Shaheer Bin Faheem1, Laiba Sultan2, Nafila Zeeshan2
1Karachi Institute of Medical Sciences (KIMS), Karachi, Sindh, Pakistan.
Abstract:
Sepsis and liver cirrhosis frequently co-occur, compounding mortality risk. However, national mortality trends involving both remain insufficiently explored. Therefore, this study aims to evaluate national trends in mortality involving coexisting liver cirrhosis and sepsis among United States adults from 1999 to 2023. We analyzed Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research data from 1999 to 2023 for adults aged ≥ 25 years with sepsis and cirrhosis listed as causes of death. Age-adjusted mortality rates per 100,000 were calculated using the 2000 United States standard population. Joinpoint regression estimated annual percent change and average annual percent change; P < .05 was considered significant. Overall, 112,937 deaths involved both liver cirrhosis and sepsis, with Age-adjusted mortality rates increased significantly during 2009 to 2015 and 2018 to 2021. Males (2.35), non-Hispanic American Indians (3.82), and elderly individuals (3.99) had the highest rates. Further south region (2.24) and rural geographics (average annual percent change: 4.45) showed peak mortality rates. Mortality from coexisting sepsis and cirrhosis is rising, especially among American Indian individuals, minorities, males, older adults, and rural populations, underscoring disparities in care and the need for targeted interventions.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow